Home › Puma Biotechnology Updates Timeline For Filing New Drug Application
 

Keywords :   


Puma Biotechnology Updates Timeline For Filing New Drug Application

2014-12-03 07:07:08| drugdiscoveryonline News Articles

Puma Biotechnology, Inc., a development stage biopharmaceutical company, recently provided an update on the timeline for filing its New Drug Application (NDA) for the approval of PB272 (neratinib) in the extended adjuvant treatment of HER2-positive early stage breast cancer

Tags: application updates drug filing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
More »